Law ❯ Corporate Law ❯ Regulatory Compliance
False Statements Federal Investigations Jay Clayton False Claims Act Corporate Misconduct Investor Protection Market Manipulation SEC Filings SEBI Regulations Federal Securities Laws Legal Proceedings Australian Securities and Investments Commission Enforcement Actions Investigations Penalties National Company Law Tribunal Court Rulings Related Party Transactions Securities and Exchange Board of India Misleading Statements Director Liability CVM
The case stems from regulatory disclosures by the SEC followed by the FDA that preceded double‑digit Telix ADS declines.